Mary Oyen
Ophthalmology · Platteville, WINPI 1770536161
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.9%), food and beverage and gifts — rather than concentrated in one kind of arrangement. AbbVie accounts for 62.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $1,475 and has fallen 85.5% since, to $213 in 2025.
Across 67 payments — averaging $40.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alcon$301
- NEW World Medical,inc.$92
- Johnson & Johnson Surgical Vision, Inc.$80
- Merck$66
- Neurelis, Inc.$40
- plus $447 from 20 others
What the payments were for
- Travel & lodging$1,45254%
- Food & beverage$1,22545%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $1,671 |
| Alcon | 9 | $301 |
| NEW World Medical,inc. | 7 | $92 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $80 |
| Merck | 4 | $66 |
| Neurelis, Inc. | 1 | $40 |
| Amarin Pharma, Inc. | 2 | $40 |
| Rayner Intraocular Lenses Limited | 2 | $39 |
| Novo Nordisk | 2 | $35 |
| Boehringer Ingelheim | 2 | $31 |
| Amgen(2 entities) | 2 | $30 |
| Bausch & Lomb Americas Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $28 |
| Astellas Pharma US Inc | 1 | $20 |
| Organon | 2 | $19 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Pfizer | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Sight Sciences, Inc. | 1 | $14 |
| The Cameron-ehlen Group, Inc. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEN$1,062
- XEN GLAUCOMA TREATMENT SYSTEM$230
- Clareon$125
How this compares
$2,697 in reported general payments places this provider in the 85th percentile of 337 ophthalmology providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 84 | $14,489 |
| Prednisolone Acetate | 175 | $9,854 |
| Timolol Maleate | 119 | $7,390 |
| Brimonidine Tartrate | 73 | $6,669 |
| IlevroNepafenac | 17 | $6,360 |
| Travoprost | 73 | $5,431 |
| LumiganBimatoprost | 17 | $4,364 |
| Brinzolamide | 20 | $4,360 |
| Latanoprost | 282 | $2,837 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 177 | $2,710 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 13 | $1,428 |
| Acetazolamide ErAcetazolamide | 14 | $838 |
| MoxifloxacinMoxifloxacin Hcl | 36 | $501 |
| Dorzolamide Hcl | 12 | $308 |
| ErythromycinErythromycin Base | 15 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisIlevro | $16 | $6,36017 claims |
| AbbVieLumigan | $1,671 | $4,36417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 337 ophthalmology providers in Wisconsin.
Other ophthalmology in Platteville
- Inder SinghRacine$2.5M
- Deepak SambharaWausau$388K
- John VukichWauwatosa$356K
- Eugene EldridgeKenosha$294K
- Michael ShapiroMadison$71K
- Douglas SalmAppleton$38K
- Julia AgapovMadison$26K
- Thomas HarveyChippewa Falls$23K
- Michael VrabecAppleton$20K
- Philip SmithMinocqua$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.